pfizer q2 2025 - Search News

News

Pfizer, PFE and Q2

Yahoo Finance · 19h

Pfizer Q2 Earnings Loom--Should You Buy, Hold, or Sell?

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around $13.58 billion, reflecting modest 2% growth on last year, and adjusted EPS near $0.

Seeking Alpha · 12h

Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript

Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsAamir Malik - Corporate ParticipantAlbert Bourla

StockStory.org on MSN · 22h

Pfizer (NYSE:PFE) Reports Upbeat Q2

Global pharmaceutical company Pfizer (NYSE:PFE) announced in Q2 CY2025, with sales up 10.3% year on year to $14.65 billion. The company expects the full year’s revenue to be around $62.5 billion, close to analysts’ estimates.

13h

Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

24m

U.S. Pfizer Records 10 Percent Growth in Q2 Revenue

Pfizer, the U.S.-based pharmaceutical giant, revealed its second-quarter financial results on Tuesday, showcasing a robust 10 ...

8hon MSN

Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

19hon MSN

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

19h

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results